KOKH kliinilised uuringud osariigis Georgia
12 uuringut haiguse KOKH jaoks otsivad osalejaid osariigis Georgia.
Linnad osariigis Georgia
Ametlik uuringutekst (inglise keeles)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Savannah
- Research Site, Tucker
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Appalachian Clinical Research- Site Number : 8400060, Adairsville
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 1. okt 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Centricity Research Columbus, Rincon
VärbamineFaas 2
Vanused 40–85 · Kõik sood · Uuendatud 30. sept 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Private Practice - Dr. David Kavtaradze- Site Number : 8400006, Cordele
- Primeway Clinical Research- Site Number : 8400121, Fayetteville
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Private Practice - Dr. David Kavtaradze- Site Number : 8400017, Cordele
VärbamineFaas 4
Vanused 40–85 · Kõik sood · Uuendatud 22. sept 2026 · NCT07053423A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Atlanta
- Research Site, Cordele
- Research Site, Decatur
- ja veel 1
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Atlanta
- Research Site, Lithonia
- Research Site, Rincon
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Cpcc-Research Llc, East Point
- Centricity Research Rincon Pulmonology, Rincon
VärbamineFaas 2/3
Vanused 35–80 · Kõik sood · Uuendatud 31. aug 2026 · NCT07363694eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Cordele
- GSK Investigational Site, Dunwoody
VärbamineFaas 3
Vanused 40–75 · Kõik sood · Uuendatud 28. juuli 2026 · NCT07177339Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
VärbamineFaas 2
Vanused 35–89 · Kõik sood · Uuendatud 15. mai 2026 · NCT05937854Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Adairsville
- GSK Investigational Site, Cordele
- GSK Investigational Site, East Point
- ja veel 1
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 9. apr 2026 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- SpeciCare, Inc, Gainesville
VärbamineVaatlusuuring
Vanused 50 ja vanemad · Kõik sood · Uuendatud 5. aug 2025 · NCT06122077Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.